
SoftBank’s Arm Plans to Pursue US-Only Listing This Year, Shuns UK
British tech giant Arm has decided on a US listing alone in 2023 as “the best way forward for the company”.
British tech giant Arm has decided on a US listing alone in 2023 as “the best way forward for the company”.
The push by iMotion to go public via an IPO is not the first for outfits operating within the same industry.
The China Securities Regulatory Commission (CSRC) recently announced rules for domestic companies considering overseas IPOs.
Over time, multiple Chinese agencies have consistently provided new rules to guide and protect national security and personal data.
Superplastic will work with Amazon Studios to develop an animated comedy series that will feature the popular “synthetic” characters – Janky and Guggimon.
Hesai Group, QuantaSing, and Structure Therapeutics are some Chinese IPOs to see a recent US listing, but they might not be the last.
BitFuFu postponed its public listing, following stablecoin issuer Circle which terminated its intention to go public in December.
Crypto exchange Kraken recently assembled a team with significant IPO experience as it plans for the future.
Cava filing for IPO could trigger an active year of public debuts compared to 2022.
Leading fintech Stripe is considering a public offering within the next year amid the broader tech selloff.
The details of the IPO have not been disclosed, but if Hesai proceeds with all the steps on time, it might be the first Chinese company to launch an IPO in the US this year.
The UK PM has been in renewed talks with relevant stakeholders regarding an Arm IPO listing on the London Stock Exchange.
Jack Ma’s giving up control has already pushed the timeline of the IPO launch for three years on Shanghai’s STAR Market.
The Chinese government appears to be easing down on its crackdown on top tech companies and this may be a perfect window for WeDoctor to launch.
Bullish recently announced it is no longer moving forward with its SPAC agenda due to the deal’s deadline arrival.